Strong human immunodeficiency virus (HIV)-specific cytotoxic T- lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef- defective HIV type 1

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 436-443

  Dyer, Wayne B ^a   Ogg, Graham S ^b   Demoitie, Marie Ange ^c   Jin, Xia ^c   Geczy, Andrew F ^a   Rowland Jones, Sarah L ^b   McMichael, Andrew J ^b   Nixon, Douglas F ^c   Sullivan, John S ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD BANK; CLINICAL ARTICLE; COHORT ANALYSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; VIREMIA; VIRUS INFECTION; VIRUS LOAD;

EID: 0032888972     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.436-443.1999     Document Type: Article

References (12)

1. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96.
2. Baba, T. W., Y. S. Jeong, D. Pennick, R. Bronson, M. F. Greene, and R. M. Ruprecht. 1995. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820-1825.
3. Binley, J. M., X. Jin, Y. Huang, L. Zhang, Y. Cao, D. D. Ho, and J. P. Moore. 1998. Persistent antibody responses but declining cytotoxic T-lymphocyte responses to multiple human immunodeficiency virus type 1 antigens in a long-term nonprogressing individual with a defective p17 proviral sequence and no detectable viral RNA expression. J. Virol. 72:3472-3474.
4. Bolton, W. Personal communication.
5. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
6. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
7. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency type 1 (HIV-1) specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL response to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
8. Clerici, M., E. A. Clark, P. Polacino, I. Axberg, L. Kuller, N. I. Casey, W. R. Morton, G. M. Shearer, and R. E. Benveniste. 1994. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8:1391-1395.
9. Cohen, J. 1997. Novel campaign to test live HIV vaccine. Science 277:1035.
10. Collins, K. L., B. K. Chen, S. A. Kalams, B. D. Walker, and D. Baltimore. 1998. HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401.
11. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
12. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellet, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.